REFERENCES
- Potenza M N. Should addictive disorders include non-substance-related conditions?. Addiction 2006; 101: 142–51, (suppl 1)
- McElroy S L, Phillips K A, Keck P E, Jr. Obsessive compulsive spectrum disorder. J Clin Psychiatry 1994; 55: 33–51, (suppl)
- Hollander E. Obsessive-compulsive spectrum disorders: an overview. Psychiatr Ann 1993; 23: 355–8
- Grant J E, Potenza M N. Compulsive aspects of impulse-control disorders. Psychiatr Clin North Am 2006; 29: 539–51
- Tamminga C A, Nestler E J. Pathological gambling: focusing on the addiction, not the activity. Am J Psychiatry 2006; 163: 180–1
- Grant J E, Potenza M N, Hollander E, et al. Multicenter evaluation of the opioid antagonist nalmefene in the treatment of pathological gambling. Am J Psychiatry 2006; 163: 303–12
- Stanley M A, Cohen L J. Trichotillomania and obsessive-compulsive disorder. Trichotillomania, D J Stein, G A Christenson, E Hollander. American Psychiatric Press, Washington, DC 1999; 225–61
- O'Sullivan R L, Mansueto C S, Lerner E A, Miguel E C. Characterization of trichotillomania: a phenomenological model with clinical relevance to obsessive-compulsive spectrum disorders. Psychiatr Clin North Am 2000; 23: 587–604
- Stanley M A, Borden J W, Mouton S G, Breckenridge J K. Nonclinical hair-pulling: affective correlates and comparison with clinical samples. Behav Res Ther 1995; 33: 179–86
- Stewart S E, Jenike M A, Keuthen N J. Severe obsessive-compulsive disorder with and without comorbid hair pulling: comparisons and clinical implications. J Clin Psychiatry 2005; 66: 864–9
- Bienvenu O J, Samuels J F, Riddle M A, et al. The relationship of obsessive-compulsive disorder to possible spectrum disorders: results from a family study. Biol Psychiatry 2000; 48: 287–93
- Christenson G A, Mackenzie T B, Mitchell J E. Characteristics of 60 adult chronic hair pullers. Am J Psychiatry 1991; 148: 365–70
- Stanley M A, Swann A C, Bowers T C, David M L, Taylor D J. A comparison of clinical features in trichotillomania and obsessive-compulsive disorder. Behav Res Ther 1992; 30: 39–44
- Christenson G A, Crow S J. The characterization and treatment of trichotillomania. J Clin Psychiatry 1996; 57: 42–9, (suppl 8)
- Potenza M N, Hollander E. Pathological gambling and impulse control disorders. Neuropsychopharmacology: the fifth generation of progress, K L Davis, D Charney, J T Coyle. Lippincott, Williams, & Wilkins, New York 2002; 1725–40
- Franklin M E, Tolin D F, Diefenbach G J. Trichotillomania. Clinical manual of impulse-control disorders, E Hollander, D J Stein. American Psychiatric Press, Washington, DC 2006; 149–73
- Lochner C, Hemmings S MJ, Kinnear C J, et al. Cluster analysis of obsessive-compulsive spectrum disorders in patients with obsessive-compulsive disorder: clinical and genetic correlates. Compr Psychiatry 2005; 46: 14–9
- American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed., text rev. APA, Washington, DC 2000
- Shaffer H J. Strange bedfellows: a critical view of pathological gambling and addiction. Addiction 1999; 94: 1445–8
- Grant J E, Potenza M N. Pathological gambling and other “behavioral addictions.”. Clinical textbook of addictive disorders, R J Frances, S I Miller, A H Mack. Guilford, New York 2005; 303–20
- Arzeno Ferrao Y, Almeida V P, Bedin N R, Rosa R, D'Arrigo Busnello E. Impulsivity and compulsivity in patients with trichotillomania or skin picking compared with patients with obsessive-compulsive disorder. Compr Psychiatry 2006; 47: 282–8
- Mansueto C. Trichotillomania in focus. OCD Foundation Newsletter 1991; 5: 10–11
- Woods D W, Flessner C A, Franklin M E, et al. Trichotillomania Learning Center–Scientific Advisory Board. The Trichotillomania Impaact Project (TIP): exploring phenomenology, functional impairment, and treatment utilization. J Clin Psychiatry 2006; 67: 1877–88
- Schlosser S, Black D W, Blum N, Goldstein R B. The demography, phenomenology, and family history of 22 persons with compulsive hair-pulling. Ann Clin Psychiatry 1994; 6: 147–52
- Black D W, Noyes R, Goldstein R B, Blum N. A family study of obsessive-compulsive disorder. Arch Gen Psychiatry 1992; 49: 362–8
- Rasmussen S A, Tsuang M T. Clinical characteristics and family history in DSM-III obsessive-compulsive disorder. Am J Psychiatry 1986; 143: 317–22
- Chambers R A, Taylor J R, Potenza M N. Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability. Am J Psychiatry 2003; 160: 1041–52
- Goodman W K, McDougle C J, Price L H, Riddle M A, Pauls D L, Leckman J F. Beyond the serotonin hypothesis: a role for dopamine in some forms of obsessive compulsive disorder?. J Clin Psychiatry 1990; 51(8)36–43, (suppl)
- O'Sullivan R L, Christenson G A, Stein D. Pharmacotherapy of trichotillomania. Trichotillomania, D J Stein, G A Christianson, E Hollander. American Psychiatric Press, Washington, DC 1999; 93–124
- Stein D J, Lochner C. Obsessive-compulsive spectrum disorders: a multidimensional approach. Psychiatr Clin North Am 2006; 29: 343–51
- O'Brien C P, McKay J. Pharmacological treatments for substance use disorders. A guide to treatments that work. 2nd ed., P E Nathan, J M Gorman. Oxford University Press, New York 2002; 125–56
- Woolley J B, Heyman I. Dexamphetamine for obsessive-compulsive disorder [Letter]. Am J Psychiatry 2003; 160: 183
- Eilam D, Szechtman H. Psychostimulant-induced behavior as an animal model of obsessive-compulsive disorder: an ethological approach to the form of compulsive rituals. CNS Spectr 2005; 10: 191–202
- Bloch M H, Landeros-Weisenberger A, Kelmendi B, Coric V, Bracken M B, Leckman J F. A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder. Mol Psychiatry 2006; 11: 622–32
- Swedo S E, Leonard H L, Rapoport J L, Lenane M C, Goldberger E L, Cheslow D L. A double-blind comparison of clomipramine and desipramine in the treatment of trichotillomania (hair pulling). N Engl J Med 1989; 321: 497–501
- Christianson G A, Mackenzie T B, Mitchell J E, Callies A L. A placebo-controlled, double-blind crossover study of fluoxetine in trichotillomania. Am J Psychiatry 1991; 148: 1566–71
- Streichenwein S M, Thornby J I. A long-term, double-blind, placebo-controlled crossover trial or the efficacy of fluoxetine for trichotillomania. Am J Psychiatry 1995; 152: 1192–6
- Pigott T A, Pato M T, Bernstein S E, et al. Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioral and biological results. Arch Gen Psychiatry 1990; 47: 926–32
- Volpicelli J R, Alterman A I, Hayashida M, O'Brien C P. Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 1992; 49: 876–80
- Martin W R, Jasinski D, Mansky P. Naltrexone, an antagonist for the treatment of heroin dependence. Arch Gen Psychiatry 1973; 23: 784–9
- Mason B J, Salvato F R, Williams L D, Ritvo E C, Cutler R B. A double-blind, placebo-controlled study of oral nalmefene for alcohol dependence. Arch Gen Psychiatry 1999; 56: 719–24
- Keuler D J, Altemus M, Michelson D, Greenberg B, Murphy D L. Behavioral effects of naloxone infusion in obsessive-compulsive disorder. Biol Psychiatry 1996; 40: 154–6
- Insel T R, Pickar D. Naloxone administration in obsessive-compulsive disorder: report of two cases. Am J Psychiatry 1983; 140: 1219–20
- Kim S W. Opioid antagonists in the treatment of impulse-control disorders. J Clin Psychiatry 1998; 59: 159–64
- Roth A S, Ostroff R B, Hoffman R E. Naltrexone as a treatment for repetitive self-injurious behaviour: an open-label trial. J Clin Psychiatry 1996; 57: 233–7
- Kim S W, Grant J E, Adson D E, Shin Y C. Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling. Biol Psychiatry 2001; 49: 914–21
- Hollander E, Kaplan A, Pallanti S. Pharmacological treatments. Pathological gambling: a clinical guide to treatment, J E Grant, M N Potenza. American Psychiatric Press, Washington, DC 2004; 189–205